These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35001603)
1. Probiotics in the treatment of Helicobacter pylori infection: reality and perspective. Isaeva G; Isaeva R Minerva Gastroenterol (Torino); 2022 Sep; 68(3):277-288. PubMed ID: 35001603 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781 [TBL] [Abstract][Full Text] [Related]
3. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study. Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644 [TBL] [Abstract][Full Text] [Related]
4. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study. Poonyam P; Chotivitayatarakorn P; Vilaichone RK Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388 [TBL] [Abstract][Full Text] [Related]
5. Novel and Effective Therapeutic Regimens for Hu Y; Zhu Y; Lu NH Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929 [No Abstract] [Full Text] [Related]
6. Are probiotics useful in Helicobacter pylori eradication? Homan M; Orel R World J Gastroenterol; 2015 Oct; 21(37):10644-53. PubMed ID: 26457024 [TBL] [Abstract][Full Text] [Related]
7. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance. Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678 [TBL] [Abstract][Full Text] [Related]
8. Probiotics for the treatment of Helicobacter pylori infection in children. Pacifico L; Osborn JF; Bonci E; Romaggioli S; Baldini R; Chiesa C World J Gastroenterol; 2014 Jan; 20(3):673-83. PubMed ID: 24574741 [TBL] [Abstract][Full Text] [Related]
9. Role of Probiotics in Eradication Therapy for Helicobacter pylori Infection. Kamiya S; Yonezawa H; Osaki T Adv Exp Med Biol; 2019; 1149():243-255. PubMed ID: 31016634 [TBL] [Abstract][Full Text] [Related]
10. Using Probiotics as Supplementation for Ji J; Yang H Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046317 [No Abstract] [Full Text] [Related]
11. The impacts of probiotics in eradication therapy of Helicobacter pylori. Bai X; Zhu M; He Y; Wang T; Tian D; Shu J Arch Microbiol; 2022 Nov; 204(12):692. PubMed ID: 36344628 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. Du YQ; Su T; Fan JG; Lu YX; Zheng P; Li XH; Guo CY; Xu P; Gong YF; Li ZS World J Gastroenterol; 2012 Nov; 18(43):6302-7. PubMed ID: 23180952 [TBL] [Abstract][Full Text] [Related]
13. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. Navarro-Rodriguez T; Silva FM; Barbuti RC; Mattar R; Moraes-Filho JP; de Oliveira MN; Bogsan CS; Chinzon D; Eisig JN BMC Gastroenterol; 2013 Mar; 13():56. PubMed ID: 23530767 [TBL] [Abstract][Full Text] [Related]
14. Development of Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459 [No Abstract] [Full Text] [Related]
16. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Furuta T; Graham DY Gastroenterol Clin North Am; 2010 Sep; 39(3):465-80. PubMed ID: 20951912 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Helicobacter pylori infection: Where are we now? Liou JM; Wu MS; Lin JT J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632 [TBL] [Abstract][Full Text] [Related]
18. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Miftahussurur M; Yamaoka Y Molecules; 2015 Apr; 20(4):6068-92. PubMed ID: 25856059 [TBL] [Abstract][Full Text] [Related]
19. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. Zhang MM; Qian W; Qin YY; He J; Zhou YH World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886 [TBL] [Abstract][Full Text] [Related]
20. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy. Ozaki H; Harada S; Takeuchi T; Kawaguchi S; Takahashi Y; Kojima Y; Ota K; Hongo Y; Ashida K; Sakaguchi M; Tokioka S; Sakamoto H; Furuta T; Tominaga K; Higuchi K Digestion; 2018; 97(3):212-218. PubMed ID: 29393194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]